Literature DB >> 19813677

Determination of complication rate of PICC lines in oncological patients.

Ghulam Haider1, Shiyam Kumar, Basit Salam, Nehal Masood, Asim Jamal, Yasmeen Abdul Rasheed.   

Abstract

OBJECTIVE: To determine the complication rate of (PICCs) peripherally inserted central catheters in cancer patients with a 1 year prospective cohort study.
METHODS: All PICCs inserted in adult cancer patients in Radiology Department of The Aga Khan University Hospital were followed prospectively till removed or patient expired and pattern of complications noted.
RESULTS: One hundred and fourty six PICCs were inserted over a period of 1 year and followed for a total of 3329 catheter-days; median placement, 14 days: range 3-218 days. Of these 67 (32.8%) PICCs were complicated and removed earlier, for a rate of 14.4/1000 PICC-days. Patients with haematologic malignancies were more likely to have complications as compared to those with solid tissue malignancies.
CONCLUSIONS: Despite a significant complication rate, PICCs are a relatively safe and cost effective method of establishing central venous access.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19813677

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  3 in total

1.  Complications with peripherally inserted central catheters (PICCs) used in hospitalized patients and outpatients: a prospective cohort study.

Authors:  Delphine Grau; Béatrice Clarivet; Anne Lotthé; Sébastien Bommart; Sylvie Parer
Journal:  Antimicrob Resist Infect Control       Date:  2017-01-28       Impact factor: 4.887

Review 2.  Peripherally inserted central catheters in critically ill patients - complications and its prevention: A review.

Authors:  Sona Duwadi; Qinghua Zhao; Birendra Singh Budal
Journal:  Int J Nurs Sci       Date:  2018-12-21

3.  Analysis of Peripherally Inserted Central Catheter Line in Cancer Patients: A Single-Center Experience.

Authors:  Sulav Sapkota; Raju Sannur; Radheshyam Naik
Journal:  South Asian J Cancer       Date:  2021-06-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.